Bharat Immunologicals (India) Financial Indicators Patterns

BIBCL -- India Stock  

INR 16.00  0.20  1.23%

You can use fundamental analysis to find out if Bharat Immunologicals is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found twenty-four available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Current Valuation, Gross Profit, Debt to Equity, as well as the relationship between Price to Book and Cash and Equivalents . Use Bharat Immunologicals to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Bharat Immunologicals to be traded at 15.52 in 30 days

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with Tata Consultancy, Reliance Industries, Reliance Industries, HDFC Bank, and HDFC BANK. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and traded on Bombay Stock Exchange.

Bharat Immunologicals Debt to Equity vs Current Valuation

Bharat Immunologicals Biologicals Corp Ltd is rated fourth in debt to equity category among related companies. It is rated below average in current valuation category among related companies reporting about  183,871,053  of Current Valuation per Debt to Equity.

Bharat Immunologicals Systematic Risk

null. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Bharat Immunologicals correlated with the market. If Beta is less than 0 Bharat Immunologicals generally moves in the opposite direction as compared to the market. If Bharat Immunologicals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bharat Immunologicals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bharat Immunologicals is generally in the same direction as the market. If Beta > 1 Bharat Immunologicals moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Bharat Immunologicals Financial Distress Probability
2% 
Chance of Financial Distress
Bharat Immunologicals Biologicals Corp Ltd has less than 2 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Bharat Immunologicals

Compare Bharat Immunologicals To Peers

Opportunity Range

August 14, 2018 Opportunity Range
Check also Trending Equities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.